Frontotemporal Disorders

BOSTON, August 5, 2026 CervoMed announced that its management team will participate in a fireside chat and investor meetings...

BOSTON, June 18, 2026 CervoMed Inc., a clinical-stage biotechnology company focused on developing therapies for age-related neurological disorders, has...